Someone describing a painful childhood should not have to wait for a brain scan before their account is taken seriously. Yet research into the biology of trauma can carry that peculiar promise: perhaps, at last, there will be something visible enough to persuade those who have remained unconvinced.
That hope deserves attention. So does the burden it places on the person seeking help.
A study listed by Nature examines cannabinoid receptor type 1 availability in people with a history of childhood trauma, using positron emission tomography. The supplied reporting identifies the subject and method, but gives no findings. It therefore offers no basis here for claiming a particular biological difference, a causal explanation or a treatment implication.
What it does invite is a question about the authority we give biological evidence in therapeutic work.
There is an understandable argument for welcoming such research. Biological investigation may help challenge the suspicion that suffering is somehow less real when its origins involve memory, relationships or childhood experience. Seeking a clearer understanding is worthwhile. The difficulty begins when a possible explanation becomes an entrance requirement for compassion.
If a biological difference were found, would someone’s account become more credible? If none were found, would it become less so? Neither judgement would be justified by the information available here. More importantly, making credibility depend on that outcome would leave the person in an impossible position, required to produce evidence they cannot supply or control.
For practitioners, there is a related temptation: to borrow the authority of neuroscience before the evidence warrants it. A technical term can make an explanation sound settled. It can also become another label a person has to live inside.
Responsible practice requires room for two kinds of uncertainty. We may not yet understand the biological significance of an experience. We may also misunderstand what that experience means to the individual describing it. A confident account of receptors would not remove the need to listen carefully.
Research should be allowed to investigate without being recruited prematurely into a therapeutic sales pitch. And the person sitting opposite a practitioner should be able to speak without wondering whether their suffering has yet acquired sufficient scientific credentials.